Market Research Logo

Thailand Pharmaceuticals and Healthcare Report Q4 2017

BMI View:

Reforms to Thailand's healthcare system aim to influence the commercial opportunities formultinational drugmakers. While a new law announced in May 2017 would reduce the privileges of stateagencies' procurement scheme and allow public healthcare facilities to purchase medicines directly frominternational drugmakers, Thailand's business environment will remain challenging for multinationalpharmaceutical firms. Cost containment pressures will also become more acute as authorities seek to curbrising healthcare spending, although this is seemingly at odds with the announced programme to clear thepatent backlog.

Headline Expenditure Projections

Pharmaceuticals: THB161.0bn (USD4.6bn) in 2016 to THB169.6bn (USD4.9bn) in 2017; +5.3% inlocal currency terms and +7.7% in US dollar terms.

Healthcare: THB892.5bn (USD25.3bn) in 2016 to THB946.4bn (USD27.4bn) in 2017; +6.0% in localcurrency terms and 8.5% in US dollar terms.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Thailand 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Latest Updates
Structural Trends
Table: Pharmaceutical Sales, Historical Data And Forecasts (Thailand 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Thailand 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Thailand 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Thailand 2013-2021)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Thailand 2013-2021)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Thailand 2013-2021)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Thailand 2013-2021)
OTC Drug Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Thailand 2013-2021)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Thailand 2015-2021)
Table: Pharmaceutical Trade Data And Forecasts Local Currency (Thailand 2015-2021)
Industry Risk/Reward Index
Asia Pacific Pharmaceuticals: Diverse Opportunities And Inherent Risks
Regulatory Review
Intellectual Property Issues
Table: Special 301 Submission 2017: Issues Raised For Thailand
Pricing Regime
Table: Price Build-Up Of Medicines In Thailand
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Major Health Insurance Programmes In Thailand
Table: Healthcare Resources (Thailand 2011-2016)
Table: Healthcare Personnel (Thailand 2011-2016)
Table: Healthcare Activity (Thailand 2011-2016)
Research & Development
Clinical Trials
Epidemiology
Table: Estimated Number Of New Cases Of Cancer In Thailand
Competitive Landscape
Research-Based Industry
Table: PReMA Members
Table: Multinational Market Activity
Generic Drugmakers
Table: Pharmaceutical Manufacturers Of Modern Drugs, 2007-2012
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Berlin Pharmaceutical Industry
Biolab
GlaxoSmithKline
Government Pharmaceutical Organisation
Merck & Co
Novartis
Pfizer
Sanofi
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Thailand 1990-2025)
Table: Key Population Ratios (Thailand 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Thailand 1990-2025)
Table: Population By Age Group (Thailand 1990-2025)
Table: Population By Age Group % (Thailand 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report